Michael Christel is Group Managing Editor of Applied Clinical Trials, Pharmaceutical Executive, and Pharmaceutical Commerce. He can be reached at firstname.lastname@example.org.
The Twists and Turns in Biopharma Dealmaking: 2024 Trends
A deep dive into the complex playing field for M&A and partnering pursuits in today’s increasingly make-or-break landscape for biopharma innovation.
Rare Disease Research: It Pays to Engage
With pursuits in rare and orphan disease beginning to move more into the drug development mainstream, the opportunities and challenges in patient engagement and trial execution for these conditions are ever-evolving, as one strategy expert in the field discusses.
Q&A: Research Data Promise vs. Reality
Today’s convergence of health data and technology is fun to watch unfold, but a focused vision on system and process integration-and the framework for continuous enrichment-will be key to future lasting gains for clinical research.
Company: Genomic Data Too Valuable to Hoard
Ambry Genetics' CEO discusses his company's decision to release the genetic information of its customers for free - a rare move, reportedly, for a commercial testing firm.
Think Big on Outsourcing: A Network Approach for Small Biopharma
Proposed partnership model explores the value of establishing alliances between CROs and networks of small and emerging biopharma companies.
New Data Revealed from a Sponsor Collaboration Focused on Safety of Long-Acting Opiates
Forging new partnerships focused on the safety of long-acting opiates is important, as public health questions surrounding drug abuse and addiction have increased, along with regulations governing these products once they reach the market.
Q&A: The Future of Clinical Trial Data Sharing
Merck & Co. Chief Medical Officer Dr. Michael Rosenblatt speaks with Applied Clinical Trials about the significant opportunities and challenges of sharing clinical trial data and the progress so far in developing a framework that, if properly pursued, could help transform the future of research and clinical care.
New Approaches to Speeding Up Clinical Trials – What Works and What Doesn’t
The concept of increasing the speed and efficiency of clinical trials is a well understood and agreed upon priority of most clinical operations professionals.
The Patients 2 Trials Consortium
Engaging and recruiting participants for clinical trials continues to be a struggle for the life sciences industry. However, emerging technology partnerships in the biopharma space may be providing hope in accelerating patient enrollment and reducing bottlenecks through a concentrated focus on target profiles.
2 Commerce Drive Cranbury, NJ 08512